Tag: Alliance for Lupus Research

Alliance for Lupus Research’s Walk With Us to Cure Lupus Program

Vincent Liuzzi, a former Wells Fargo Bank district manager and regional president, currently serves as EVP and Chief Banking Officer for DNB First. A committed member of the community, Vince Liuzzi supports several charities and has served as chair and co-chair for several foundations. In 2013, he was Philadelphia’s chair for the Alliance for Lupus Research’s Walk With Us to Cure Lupus.

As a part of the Alliance for Lupus Research’s commitment to treating, preventing, and curing lupus, the Walk with Us to Cure Lupus program began with its first walk in Washington, DC, in 2002. Since that time, the program has raised over $25 million through the help of volunteers around the United States. Donating 100 percent of the raised funds to lupus research programs, Walk with Us to Cure Lupus brings together friends, coworkers, and families looking to share their stories and spirit.

Individuals wishing to participate in the walk have a variety of options available to them. The program requests that each individual raise at least $25 for the walk, but not every individual needs to walk in order to donate. The online registration system allows for registration as a volunteer, walker, or virtual walker. Virtual walkers raise funds despite being unable to attend the event. Through personal webpages and fundraising tools, they support the cause and act as Team Captains without being physically present.

The Alliance for Lupus Research also maintains a virtual fundraising event for individuals living in an area without an established walk. These events provide communities with the necessary tools for hosting their own local walk with personalized locations, lengths, and times.

Research Funded by the Alliance for Lupus Research

A complex autoimmune disease, lupus proves difficult not just to treat, but even to diagnose. The Alliance for Lupus Research (ALR) maintains a dedication to funding research efforts conducted by the brightest minds in science in the hope of a better future. ALR focuses on a multi-pronged strategy that involves a better understanding of the disease and how it functions, rather than simply investing in better therapies.

Since its inception, ALR has allocated more than $72 million to research on lupus and potential treatment options for it. This funding has translated into more than 150 studies that have made several major breakthroughs. Studies funded by ALR have identified the genes responsible for the disease, produced new treatment drugs approved by the Food and Drug Administration, and created important new technologies, such as ImmunoChip, that will fuel further research.

Individuals can learn more about lupus and the fight against the disease online at LupusResearch.org. The website also outlines ways in which individuals can contribute to ALR’s efforts.